About onethird of new drugs introduced in the US from  to  were approved by government regulators on the basis of a single large clinical trial according to a new study The wide variation in evidence behind new drugs approved by the US Food and Drug Administration should be more clearly communicated to the public according to the authors of the study which was published Tuesday in the Journal of the American Medical Association